Previous close | 25.60 |
Open | N/A |
Bid | 57.10 |
Ask | 60.20 |
Strike | 165.00 |
Expiry date | 2024-10-18 |
Day's range | 25.60 - 25.60 |
Contract range | N/A |
Volume | |
Open interest | 1 |
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
The commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.